Evaluation of Parkinson Disease and Alzheimer Disease with the Use of Neuromelanin MR Imaging and123I-Metaiodobenzylguanidine Scintigraphy

Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease

(2011) Ioannis U Isaias et al.   BMC Neurology

Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson’s disease

(2011) Kenichi Kashihara et al.   JOURNAL OF CLINICAL NEUROSCIENCE

T1-Weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease

(2011) Stefan T. Schwarz et al.   MOVEMENT DISORDERS

Sequential imaging analysis using MIBG scintigraphy revealed progressive degeneration of cardiac sympathetic nerve in Parkinson’s disease

(2010) M. Watanabe et al.   EUROPEAN JOURNAL OF NEUROLOGY

123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders

(2010) Olivier Rascol et al.   MOVEMENT DISORDERS

Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine

(2010) M. T. Heneka et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Functional Consequences of Locus Coeruleus Degeneration in Alzheimers Disease

(2008) David Weinshenker   Current Alzheimer Research